Neuland Lab Share Price

₹ 19,575.00

-₹125.00 (-0.63%)
1D
Last updated 02 Nov, 2026, 15:57 IST
NSE: NEULANDLAB
|
Pharmaceuticals

Neuland Lab Share Price Today

As of 3 Nov 2026, Neuland Lab share price is ₹19,575.00. The stock opened at ₹19,700.00, compared to its previous close of ₹19,700.00. During today's trading session, Neuland Lab share price moved in the range of ₹19,271.00 to ₹19,800.00, with an average price of ₹19,535.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹11,500.00 and a high of ₹24,225.00. On the performance front, Neuland Lab share price has increased by 30.47% over the last six months and is up 18.83% on a year-on-year basis.

Share price over the last 1 day fell from 19570.00 to 19515.00, ranging between 19271.00 and 19735.00.

₹19,271.00
0.63% down today
₹19,800.00
1D LOW
1D HIGH

Neuland Lab Stock Insights

Latest Earning
Op Profit TrendUp by 41.19% YoY
Latest Earning
Net Profit TrendUp by 39.94% YoY
Latest Earning
Revenue TrendUp by 37.12% YoY
Stock Performance
OutperformingBeat Nifty by 8.91 % in last 3 month
Shareholding Pattern
PromoterPromoter decreased stake by 1.09%
Shareholding Pattern
DIIDII decreased stake by 1.30%
Shareholding Pattern
FIIFII increased stake by 4.02%
Technical Indicators
MACD CrossThe MACD line crossed above the signal line on 1 Day interval.
Neuland Lab stock performance
Open₹19,700.00
High₹19,800.00
Low₹19,271.00
Prev. close₹19,700.00
Neuland Lab trading activity
Volume61,848
Average traded price₹19,515.53
Last traded time03:57:38 02 Nov
Last traded quantity1

Circuit
L
H
₹15,760.00
₹23,640.00
52-week
L
H
₹11,500.00
₹24,225.00
Mkt Cap Cr
25,276.29

P/E
50.78

P/B
13.49

ROA
16.99%
ROE
19.42%

ROCE
23.57%

Quick Ratio
1.37

EV/EBITDA
31.78

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Neuland Labs. has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Neuland Labs. appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Neuland Labs. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Neuland Lab Company Background

ISIN
INE794A01010
Sector Market Cap
₹ 25,276.29 Cr

Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.

Neuland Lab Financial Highlights

  • Revenue: Neuland Lab reported revenue of ₹2,053.16 crore in FY26 vs ₹1,497.35 crore in FY25. It showed an increase of 37.12% on a yearly basis.
  • Operating Profit: Neuland Lab reported an operating profit of ₹488.98 crore in FY26 vs ₹346.33 crore in FY25. It showed an increase of 41.19% on a year-on-year basis.
  • Net Profit: Neuland Lab reported a net profit of ₹364.00 crore in FY26 vs ₹260.11 crore in FY25. It showed an increase of 39.94% on a yearly basis.

Neuland Lab Quarterly Result Highlights

  • Neuland Lab reported revenue of ₹650.07 crore in Jun 2026, compared with ₹788.71 crore in Mar 2026, representing a decrease of 17.58% on a quarter-on-quarter (QoQ) basis.
  • Neuland Lab reported an operating profit of ₹197.85 crore in Jun 2026, compared with ₹287.49 crore in Mar 2026, representing a decrease of 31.18% on a quarter-on-quarter (QoQ) basis.
  • Neuland Lab reported a profit of ₹147.67 crore in Jun 2026, compared with ₹212.67 crore in Mar 2026, reflecting a decrease of 30.56% on a QoQ basis.
  • The earnings per share (EPS) of Neuland Lab stood at ₹283.71 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
32.26%
FII
21.93%
Other DII
3.80%
Retail and other
29.55%
Mutual funds
12.45%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202520.90%
Mar 202620.46%
Jun 202621.08%
Sep 202621.93%

Neuland Lab Investment Returns

1 day
-0.63%

1 week
+2.73%

1 month
-8.97%

1 year
+18.83%

3 years
+404.63%

5 years
+1080.57%

Neuland Lab Share Price History

Neuland Lab share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹19,700.00 / ₹19,575.00
-0.63%
30 Oct 26
₹19,345.00 / ₹19,700.00
+2.18%
29 Oct 26
₹19,995.00 / ₹19,280.00
-3.46%
28 Oct 26
₹19,200.00 / ₹19,970.00
+3.39%
Show more

Neuland Lab Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,022.99₹1,476.84₹1,558.58₹1,191.20
Other Income₹30.17₹20.51₹12.54₹9.75
Total Revenue₹2,053.15₹1,497.35₹1,571.12₹1,200.95
Total Expenses₹1,564.17₹1,227.42₹1,169.69₹985.20
Profit Before Tax₹488.98₹346.33₹401.44₹215.75
Tax₹124.98₹86.22₹101.36₹52.23
Profit After Tax₹364.00₹260.11₹300.08₹163.52
EPS - Basic₹283.71₹202.74₹233.89₹127.45
EPS - Diluted₹283.71₹202.74₹233.89₹127.45

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹488.98₹346.33₹401.44₹215.75
Income before WC changes₹591.63₹334.35₹463.51₹293.67
Change in Assets-₹359.46₹28.58-₹99.00-₹153.28
Change in Liabilities₹218.04₹29.21₹8.27₹140.45
Change in WC-₹141.42₹57.78-₹90.73-₹12.83
Cash flow from Operations₹346.68₹317.40₹261.18₹237.21
Cash flow from Investing-₹423.73-₹298.16-₹149.69-₹61.50
Cash flow from Financing₹20.98₹24.96-₹69.28-₹135.80
Total Cash Flow-₹56.08₹44.21₹42.21₹39.92
Cash (Start of the year)₹131.93₹87.58₹45.42₹5.09
Cash (End of the year)₹76.67₹131.93₹87.58₹45.42

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,447.01₹1,040.38₹911.48₹818.87
Current Assets₹1,483.13₹1,139.50₹921.08₹760.89
Total Assets₹2,930.14₹2,179.88₹1,832.56₹1,579.76
Current Liabilities₹710.20₹465.69₹427.68₹438.96
Net Current Asset₹772.93₹673.81₹493.40₹321.94
Non-Current Liabilities₹345.47₹189.39₹122.17₹146.71
Equity Capital₹1,874.47₹1,524.81₹1,282.70₹994.10
Total Equity & Liabilities₹2,930.14₹2,179.88₹1,832.56₹1,579.76

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,022.99₹1,476.84₹1,558.58₹1,191.20
Other Income₹30.16₹20.51₹12.54₹9.75
Total Revenue₹2,053.15₹1,497.35₹1,571.12₹1,200.95
Total Expenses₹1,565.42₹1,228.38₹1,170.36₹985.73
Profit Before Tax₹487.73₹345.37₹400.77₹215.21
Tax₹124.63₹85.95₹101.17₹52.09
Profit After Tax₹363.11₹259.43₹299.60₹163.12
EPS - Basic₹283.01₹202.20₹233.51₹127.14
EPS - Diluted₹283.01₹202.20₹233.51₹127.14

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹487.73₹345.37₹400.77₹215.21
Income before WC changes₹590.38₹333.38₹462.84₹293.14
Change in Assets-₹359.18₹28.60-₹98.86-₹153.35
Change in Liabilities₹219.78₹30.15₹7.64₹142.31
Change in WC-₹139.40₹58.75-₹91.22-₹11.04
Cash flow from Operations₹347.58₹317.51₹260.06₹238.53
Cash flow from Investing-₹423.74-₹298.14-₹149.67-₹61.50
Cash flow from Financing₹20.98₹24.96-₹69.28-₹135.80
Total Cash Flow-₹55.18₹44.33₹41.11₹41.24
Cash (Start of the year)₹130.38₹86.07₹44.96₹3.72
Cash (End of the year)₹75.31₹130.38₹86.07₹44.96

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,446.97₹1,040.35₹911.46₹819.00
Current Assets₹1,481.37₹1,137.82₹919.47₹760.34
Total Assets₹2,928.34₹2,178.17₹1,830.93₹1,579.34
Current Liabilities₹719.24₹472.84₹433.80₹445.75
Net Current Asset₹762.12₹664.98₹485.67₹314.59
Non-Current Liabilities₹343.24₹187.54₹120.59₹145.22
Equity Capital₹1,865.85₹1,517.79₹1,276.54₹988.36
Total Equity & Liabilities₹2,928.34₹2,178.17₹1,830.93₹1,579.34
* All values are in INR Crore
Neuland Lab market depth
Bid quantityBid priceAsk priceAsk quantity
001957518
0000
0000
0000
0000
Total bid quantity0
Total ask quantity18
Neuland Lab technical summary
Bearish indicators4
Neutral indicators4
Bullish indicators0
OverallStrong Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
41.54
Neutral

ATR (14)
731.79
Neutral

STOCH(9,6)
80
Bearish

STOCH RSI (14)
97.19
Bearish

ADX(9)
53.71
Bearish

UO(9)
58.55
Neutral

ROC(12)
-3.24
Bearish

WillR(14)
-49.52
Neutral
Period
Simple value
Exponential vaue

5D
19464
19498.55

10D
19299
19581.74

20D
20145.75
20082.04

50D
21748.96
20751.48

100D
20496.01
20066.39
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Neuland Lab
Pharmaceuticals
Add Stock
Add Another

Neuland Lab Latest News

2 months ago
Neuland Labs to PTC Industries: 5 NIFTY500 firms where profit growth beat revenue growth in Q1FY27
2 months ago
Navin Fluorine, Cohance Lifesciences, Neuland Labs shares surge amid spike in trading activity
2 months ago
Neuland Laboratories shares surge over 11%, hit record high on strong June quarter earnings
4 months ago
Cohance Lifesciences, Piramal Pharma, Kirloskar Oil shares surge amid heavy volumes; check full list
Showing news item 1 of 4

Neuland Lab Share Price FAQs












Please be aware that Neuland Lab stock prices are subject to continuous fluctuations due to various factors.